Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents

  • Antimicrob Agents Chemother. 1999 Sep;43(9):2320-2. doi: 10.1128/AAC.43.9.2320.
C Betriu  1 ,  M Gómez ,  M L Palau ,  A Sánchez ,  J J Picazo
Affiliations
  • 1. Servicio de Microbiología Clínica, Hospital Clínico San Carlos, 28040 Madrid, Spain. [email protected]
PMID: 10471590 DOI: 10.1128/AAC.43.9.2320
Abstract

The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 Other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 microg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 microg/ml, respectively.

Products